$EHC
Encompass Health Corp Stock $ehc

$ehc Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000078516114000013 Filed on February 20, 2014

Income Statement

Concept	2013 Q4	2013 Q2	2012 Q4
Revenue	$572.1M	$564.5M	$552.9M
YoY Change	3.47%	5.83%	6.72%
Cost Of Revenue	$27.10M	$26.60M	$26.20M
YoY Change	3.44%	2.7%	0.38%
Gross Profit	$541.4M	$530.9M	$519.5M
YoY Change	4.22%	5.97%	6.92%
Gross Profit Margin	94.63%	94.05%	93.96%
Selling, General & Admin	$315.5M	$317.2M	$315.0M
YoY Change	0.16%	4.62%	5.63%
% of Gross Profit	58.27%	59.75%	60.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.20M	$23.10M	$21.70M
YoY Change	16.13%	15.5%	7.43%
% of Gross Profit	4.65%	4.35%	4.18%
Operating Expenses	$422.4M	$419.3M	$414.7M
YoY Change	1.86%	5.46%	6.31%
Operating Profit	$119.0M	$111.6M	$104.8M
YoY Change	13.55%	7.93%	9.39%
Interest Expense	-$23.50M	-$21.10M	-$21.30M
YoY Change	10.33%	6.03%	7.04%
% of Operating Profit	-19.75%	-18.91%	-20.32%
Other Income/Expense, Net	$1.300M	$1.900M	$1.100M
YoY Change	18.18%	375.0%	-8.33%
Pretax Income	$94.60M	$92.40M	$81.90M
YoY Change	15.51%	10.92%	-0.97%
Income Tax	$30.50M	-$86.50M	$24.50M
% Of Pretax Income	32.24%	-93.61%	29.91%
Net Earnings	$48.90M	$165.2M	$47.00M
YoY Change	4.04%	253.75%	-6.0%
Net Earnings / Revenue	8.55%	29.26%	8.5%
Basic Earnings Per Share	-$0.31	$1.82	$0.43
Diluted Earnings Per Share	-$0.31	$1.66	$0.43
COMMON SHARES
Basic Shares Outstanding	87.43M shares	86.10M shares	95.66M shares
Diluted Shares Outstanding		99.80M shares

Balance Sheet

Concept	2013 Q4	2013 Q2	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$64.50M	$68.70M	$132.8M
YoY Change	-51.43%	67.15%	341.2%
Cash & Equivalents	$64.50M	$68.70M	$132.8M
Short-Term Investments
Other Short-Term Assets	$115.1M	$111.6M	$117.2M
YoY Change	-1.79%	-18.95%	-15.13%
Inventory
Prepaid Expenses
Receivables	$261.8M	$273.7M	$249.3M
Other Receivables	$12.40M	$0.00	$18.00M
Total Short-Term Assets	$580.4M	$591.5M	$636.8M
YoY Change	-8.86%	39.34%	29.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$910.5M	$793.3M	$748.0M
YoY Change	21.72%	10.35%	12.58%
Goodwill	$456.9M	$13.70M	$437.3M
YoY Change	4.48%	-96.75%	3.7%
Intangibles	$88.20M	$86.80M	$73.20M
YoY Change	20.49%	25.8%	26.86%
Long-Term Investments	$18.90M		$19.20M
YoY Change	-1.56%		-29.15%
Other Assets	$144.1M	$138.1M	$135.4M
YoY Change	6.43%	7.22%	5.53%
Total Long-Term Assets	$1.954B	$1.920B	$1.787B
YoY Change	9.32%	1.53%	0.44%
TOTAL ASSETS
Total Short-Term Assets	$580.4M	$591.5M	$636.8M
Total Long-Term Assets	$1.954B	$1.920B	$1.787B
Total Assets	$2.534B	$2.512B	$2.424B
YoY Change	4.55%	8.46%	6.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.90M	$57.30M	$45.30M
YoY Change	36.64%	-3.86%	-0.22%
Accrued Expenses	$114.6M	$254.3M	$111.6M
YoY Change	2.69%	-4.04%	3.81%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$12.30M		$13.60M
YoY Change	-9.56%		-171.96%
Total Short-Term Liabilities	$311.6M	$311.6M	$300.9M
YoY Change	3.56%	-4.0%	-3.93%
LONG-TERM LIABILITIES
Long-Term Debt	$1.505B	$1.320B	$1.240B
YoY Change	21.4%	8.23%	0.33%
Other Long-Term Liabilities	$44.00M	$131.4M	$24.00M
YoY Change	83.33%	-3.24%	-21.05%
Total Long-Term Liabilities	$44.00M	$131.4M	$24.00M
YoY Change	83.33%	-90.3%	-98.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$311.6M	$311.6M	$300.9M
Total Long-Term Liabilities	$44.00M	$131.4M	$24.00M
Total Liabilities	$1.959B	$1.763B	$1.671B
YoY Change	17.21%	4.94%	-0.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.101B	-$2.208B	-$2.425B
YoY Change	-13.35%		-7.09%
Common Stock	$1.000M	$1.000M	$1.000M
YoY Change	0.0%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$404.6M	$404.0M	$163.3M
YoY Change	147.76%		9.74%
Treasury Stock Shares	14.65M shares	14640B shares	5.234M shares
Shareholders Equity	$344.6M	$274.8M	$291.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.534B	$2.512B	$2.424B
YoY Change	4.55%	8.46%	6.74%

Cashflow Statement

Concept	2013 Q4	2013 Q2	2012 Q4
OPERATING ACTIVITIES
Net Income	$48.90M	$165.2M	$47.00M
YoY Change	4.04%	253.75%	-6.0%
Depreciation, Depletion And Amortization	$25.20M	$23.10M	$21.70M
YoY Change	16.13%	15.5%	7.43%
Cash From Operating Activities	$100.9M	$105.4M	$109.3M
YoY Change	-7.69%	-7.54%	-15.53%
INVESTING ACTIVITIES
Capital Expenditures	-$34.10M	-$42.70M	-$31.50M
YoY Change	8.25%	-29.19%	-33.26%
Acquisitions		$28.90M
YoY Change		1276.19%
Other Investing Activities	$5.100M	-$10.80M	-$23.00M
YoY Change	-122.17%	-320.41%	127.72%
Cash From Investing Activities	-$29.00M	-$53.50M	-$54.50M
YoY Change	-46.79%	-3.43%	-4.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-72.40M	-63.30M	-85.20M
YoY Change	-15.02%	2.43%	-5.02%
NET CHANGE
Cash From Operating Activities	100.9M	105.4M	109.3M
Cash From Investing Activities	-29.00M	-53.50M	-54.50M
Cash From Financing Activities	-72.40M	-63.30M	-85.20M
Net Change In Cash	-500.0K	-11.40M	-30.40M
YoY Change	-98.36%	256.25%	72.73%
FREE CASH FLOW
Cash From Operating Activities	$100.9M	$105.4M	$109.3M
Capital Expenditures	-$34.10M	-$42.70M	-$31.50M
Free Cash Flow	$135.0M	$148.1M	$140.8M
YoY Change	-4.12%	-15.03%	-20.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	12400000	USD
CY2012Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	18000000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	61900000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	45300000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	261800000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	249300000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	712600000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	728100000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1400000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-100000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2876600000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2849400000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	71000000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24100000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20300000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24800000	USD
CY2011	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	136900000	USD
CY2013	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	87800000	USD
CY2012	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	180100000	USD
CY2012	us-gaap	Advertising Expense AdvertisingExpense	5000000	USD
CY2011	us-gaap	Advertising Expense AdvertisingExpense	4300000	USD
CY2013	us-gaap	Advertising Expense AdvertisingExpense	5200000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	28700000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23100000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	10000000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13400000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17300000	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15200000	USD
CY2013	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	9500000	USD
CY2012	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	10100000	USD
CY2011	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	11100000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2013Q4	us-gaap	Assets Assets	2534400000	USD
CY2012Q4	us-gaap	Assets Assets	2424200000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	636800000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	580400000	USD
CY2013Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	100000	USD
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	400000	USD
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	5000000	USD
CY2013Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	300000	USD
CY2013Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	47900000	USD
CY2012Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	54400000	USD
CY2013	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	200000	USD
CY2012	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	1500000	USD
CY2013	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	500000	USD
CY2012	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	100000	USD
CY2012Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	963700000	USD
CY2013Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1085200000	USD
CY2012Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	59500000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	13600000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	109200000	USD
CY2012	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	184800000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	323200000	USD
CY2012	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2183600000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2278100000	USD
	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	100000	USD
	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	11800000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	29300000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities	400000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	28900000	USD
CY2012Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt	5700000	USD
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt	4300000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	11300000	USD
CY2013Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	88900000	USD
CY2012Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	71900000	USD
CY2013Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	124600000	USD
CY2012Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	169800000	USD
CY2013Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	77000000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	175500000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	12300000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	13500000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	13400000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	13500000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	86600000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	88900000	USD
CY2012Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	110300000	USD
CY2013Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	47600000	USD
CY2011	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	-8800000	USD
CY2013	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	-21300000	USD
CY2012	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	-18900000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64500000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132800000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30100000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48300000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18200000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-68300000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	102700000	USD
CY2012	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	7700000	USD
CY2013	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	3300000	USD
CY2011	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-700000	USD
CY2013	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1900000	USD
CY2011	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	9100000	USD
CY2012	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	2000000	USD
CY2004Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2900000	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10000000	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.36
CY2011	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.00
CY2012	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.00
CY2013Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2013Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2013Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102648302	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100919297	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	1000000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	1000000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	208000000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	186600000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	322100000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	50900000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	57800000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	45900000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	379900000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	253900000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	237500000	USD
CY2012Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	46000000	USD
CY2013Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	32500000	USD
CY2012Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	0	USD
CY2013Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	13500000	USD
CY2006Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	32.7869	shares
CY2013	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	We may at any time cause the shares of preferred stock to be automatically converted into shares of our common stock at the conversion rate then in effect if the closing sale price of our common stock for 20 trading days within a period of 30 consecutive trading days ending on the trading day before the date we give the notice of forced conversion exceeds 150% of the conversion price of the preferred stock. If we are subject to a fundamental change, as defined in the certificate of designation of the preferred stock, each holder of shares of preferred stock has the right, subject to certain limitations, to require us to purchase with cash any or all of its shares of preferred stock at a purchase price equal to 100% of the accreted liquidation preference, plus any accrued and unpaid dividends to the date of purchase. In addition, if holders of the preferred stock elect to convert shares of preferred stock in connection with certain fundamental changes, we will in certain circumstances increase the conversion rate for such shares of preferred stock.
CY2012Q4	us-gaap	Cost Method Investments CostMethodInvestments	1600000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	1400000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	1718000000	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	1619500000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	1764900000	USD
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1400000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	900000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	700000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5900000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6300000	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	600000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5200000	USD
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-800000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5400000	USD
CY2012Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1253500000	USD
CY2013Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1517500000	USD
CY2011Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	120000000	USD
CY2010Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	525000000	USD
CY2012Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	275000000	USD
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	48200000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	104200000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	11300000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6400000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	36500000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	102700000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	17300000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	7700000	USD
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11700000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4900000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1200000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6500000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	14700000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	19800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	584500000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	597600000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	493300000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	531000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	-139000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	-137500000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	393500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	354300000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	553800000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	557800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	139000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	137500000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	393500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	354300000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	432500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	416500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	400000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	11900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	11100000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	26800000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	26800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	15300000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	14900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	19000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	18900000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	30700000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	28500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30700000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39800000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	60500000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	26800000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	26500000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	29200000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3300000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	300000	USD
CY2011	us-gaap	Depreciation Depreciation	52500000	USD
CY2012	us-gaap	Depreciation Depreciation	59000000	USD
CY2013	us-gaap	Depreciation Depreciation	67900000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	78800000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94700000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82500000	USD
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	800000	USD
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-800000	USD
CY2011	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	21100000	USD
CY2011	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	37900000	USD
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-100000	USD
CY2012	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1300000	USD
CY2011	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	66300000	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	200000	USD
CY2012	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	200000	USD
CY2012	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	1000000	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	200000	USD
CY2011	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	95700000	USD
CY2013	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32000000	USD
CY2013	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	21000000	USD
CY2011	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	26000000	USD
CY2012	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	23900000	USD
CY2012Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	0	USD
CY2013Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	0	USD
CY2012Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2013Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.91
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.82
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.58
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	2.58
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.67
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.91
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.58
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.032
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.319
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.153
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.028
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.116
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.023
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.065
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.051
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.051
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.013
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.030
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.040
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.003
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.072
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.287
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85700000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	90800000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8600000	USD
CY2012Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2800000	USD
CY2013Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2900000	USD
CY2012	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	11000000	USD
CY2011	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	13000000	USD
CY2013	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	11400000	USD
CY2012	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	4900000	USD
CY2013Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	18900000	USD
CY2012Q4	us-gaap	Equity Method Investments EquityMethodInvestments	19200000	USD
CY2013Q4	us-gaap	Equity Method Investments EquityMethodInvestments	18900000	USD
CY2011	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	700000	USD
CY2012Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	58000000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	52800000	USD
CY2012Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	21400000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	16600000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	2400000	USD
CY2012Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	6600000	USD
CY2011	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	26500000	USD
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	24600000	USD
CY2012	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	28300000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	52800000	USD
CY2012Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	58000000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	30800000	USD
CY2012Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	31000000	USD
CY2012	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	28300000	USD
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	24600000	USD
CY2011	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	26500000	USD
CY2012Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	36600000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	36200000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	700000	USD
CY2012Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	1200000	USD
CY2013	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	74300000	USD
CY2012	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	83300000	USD
CY2011	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	87000000	USD
CY2012Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	19200000	USD
CY2012	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	2100000	USD
CY2013	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	15600000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	135600000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	152700000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	17600000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6200000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	8600000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	15800000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	208800000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	240900000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	88200000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73200000	USD
CY2012Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	324500000	USD
CY2013Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	344400000	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2400000	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-38800000	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4000000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	119100000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	117900000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110500000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	456900000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	437300000	USD
CY2013Q2	us-gaap	Goodwill Goodwill	13700000	USD
CY2010Q4	us-gaap	Goodwill Goodwill	420300000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	421700000	USD
CY2011	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1400000	USD
CY2012	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2013	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	13700000	USD
CY2013Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2011	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2012	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2012	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	15600000	USD
CY2013	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	300000	USD
CY2013	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	2273200000	USD
CY2011	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	2026900000	USD
CY2012	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	2161900000	USD
CY2012Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	537000000	USD
CY2012Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	552900000	USD
CY2012Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	538600000	USD
CY2012Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	533400000	USD
CY2013Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	564000000	USD
CY2013Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	572100000	USD
CY2013Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	564500000	USD
CY2013Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	572600000	USD
CY2013	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1100000	USD
CY2011	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	6800000	USD
CY2012	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	158800000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	324700000	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	180500000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	57800000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	50900000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	47000000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	340000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	395200000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	242900000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	231400000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	205800000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	382500000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	56400000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	60400000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	57200000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	57400000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	73200000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	66300000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	178900000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	64100000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	1.62
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	2.59
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	1.39
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.62
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.39
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.38
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.41
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.39
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.44
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.48
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.59
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.31
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.61
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.82
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.39
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.44
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.41
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.62
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.38
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.59
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.59
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.66
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.48
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.31
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1100000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4500000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	48800000	USD
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-400000	USD
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3500000	USD
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-500000	USD
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1900000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	100000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-900000	USD
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	100000	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-400000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	49900000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4500000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1100000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.52
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.01
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.05
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.52
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.04
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2011	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12000000	USD
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11200000	USD
CY2012	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12700000	USD
CY2013Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	100000	USD
CY2012Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	-200000	USD
CY2013	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-200000	USD
CY2012	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-700000	USD
CY2011	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-4700000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	108600000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12700000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37100000	USD
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24500000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26900000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29100000	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28100000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35200000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33500000	USD
CY2013Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30500000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-86500000	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	28000000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	11800000	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	9100000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	12500000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6400000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	800000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4400000	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37100000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	55100000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	51300000	USD
CY2011	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	23600000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	5000000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5700000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12500000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-600000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4800000	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1200000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	3100000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	14000000	USD
CY2012	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1000000	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	10500000	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	13100000	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	12000000	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1500000	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2800000	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2500000	shares
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	88200000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73200000	USD
CY2012	us-gaap	Interest And Debt Expense InterestAndDebtExpense	94100000	USD
CY2013	us-gaap	Interest And Debt Expense InterestAndDebtExpense	100400000	USD
CY2011	us-gaap	Interest And Debt Expense InterestAndDebtExpense	119400000	USD
CY2012	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1000000	USD
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	500000	USD
CY2013	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1900000	USD
CY2013	us-gaap	Interest Paid InterestPaid	99400000	USD
CY2011	us-gaap	Interest Paid InterestPaid	115400000	USD
CY2012	us-gaap	Interest Paid InterestPaid	88100000	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	23800000	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25900000	USD
CY2012Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	20800000	USD
CY2013Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	20300000	USD
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1089700000	USD
CY2012	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1050200000	USD
CY2011	us-gaap	Labor And Related Expense LaborAndRelatedExpense	982000000	USD
CY2013Q4	us-gaap	Land Land	96000000	USD
CY2012Q4	us-gaap	Land Land	79600000	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	65000000	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	62300000	USD
CY2012Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	39500000	USD
CY2013Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	36500000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1671300000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1959000000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2534400000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2424200000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	300900000	USD
CY2012	us-gaap	Management Fees Revenue ManagementFeesRevenue	0	USD
CY2013	us-gaap	Management Fees Revenue ManagementFeesRevenue	0	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	311600000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	4600000	USD
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	5200000	USD
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	600000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	600000	USD
CY2012Q4	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2013Q4	us-gaap	Line Of Credit LineOfCredit	45000000	USD
CY2012Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0205
CY2013Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.019
CY2012Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1239900000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1505200000	USD
CY2012Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	13600000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	12300000	USD
CY2011	us-gaap	Management Fees Revenue ManagementFeesRevenue	0	USD
CY2013Q4	us-gaap	Marketable Securities Restricted MarketableSecuritiesRestricted	47600000	USD
CY2012Q4	us-gaap	Marketable Securities Restricted MarketableSecuritiesRestricted	55800000	USD
CY2013Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	42900000	USD
CY2012Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	39400000	USD
CY2013Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Thereafter MinimumLeasePaymentsSaleLeasebackTransactionsThereafter	14000000	USD
CY2013Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Five Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFiveYears	2700000	USD
CY2013Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Four Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears	2700000	USD
CY2013Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within One Year MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear	2700000	USD
CY2013Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Three Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears	2700000	USD
CY2013Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Two Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears	2700000	USD
CY2012Q4	us-gaap	Minority Interest MinorityInterest	112500000	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	124100000	USD
CY2011	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	40500000	USD
CY2012	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	45400000	USD
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	40400000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-336300000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-130000000	USD
CY2011	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	45900000	USD
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	50900000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-312400000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24600000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226200000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-178800000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	470300000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	411500000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	342700000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	208700000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	185000000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	323600000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	47000000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	46700000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	44200000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	47100000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	58200000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	51300000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	48900000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	165200000	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	57800000	USD
CY2012Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12600000	USD
CY2012Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13200000	USD
CY2012Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12800000	USD
CY2012Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12300000	USD
CY2013Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14100000	USD
CY2013Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14600000	USD
CY2013Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13800000	USD
CY2013Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	15300000	USD
CY2012	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	47100000	USD
CY2013	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	52000000	USD
CY2011	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	42300000	USD
CY2013	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	5800000	USD
CY2012	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	3800000	USD
CY2011	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	3600000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182700000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	231000000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	160300000	USD
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1000000	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	36000000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	100700000	USD
CY2012	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	4700000	USD
CY2013	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	4900000	USD
CY2011	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	2800000	USD
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2011	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	400000	USD
CY2012	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	13900000	USD
CY2013Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	28
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	253900000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	37900000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	10400000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	22000000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	26300000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	31000000	USD
CY2011	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	4700000	USD
CY2011	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	24200000	USD
CY2013	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	20300000	USD
CY2012	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	20600000	USD
CY2013	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	40300000	USD
CY2012	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	41200000	USD
CY2011	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	38500000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	66900000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	64800000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	66300000	USD
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	929000000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	144100000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	135400000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	1600000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-1600000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-700000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1600000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1500000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-700000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	900000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2011	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-100000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2012	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-700000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-700000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1600000	USD
CY2013	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	323000000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2700000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4500000	USD
CY2012	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	303800000	USD
CY2011	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	288300000	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	122800000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	130400000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24000000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44000000	USD
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9300000	USD
CY2011	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7900000	USD
CY2012	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3000000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8500000	USD
CY2012Q4	us-gaap	Other Notes Payable OtherNotesPayable	36800000	USD
CY2013Q4	us-gaap	Other Notes Payable OtherNotesPayable	47600000	USD
CY2011	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2012	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	12400000	USD
CY2011	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	10900000	USD
CY2013	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2012	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2012	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	900000	USD
CY2013	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-500000	USD
CY2011	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	900000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	234100000	USD
CY2011	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	0	USD
CY2013	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	2800000	USD
CY2012	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	46000000	USD
CY2012	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2013	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	15700000	USD
CY2011	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2011	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	44200000	USD
CY2013	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	46300000	USD
CY2012	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	49300000	USD
CY2012	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	24600000	USD
CY2011	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	26000000	USD
CY2013	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	23000000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	28900000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3100000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4900000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	140800000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	195200000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100300000	USD
CY2012	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	9100000	USD
CY2011	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	8400000	USD
CY2013	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	9200000	USD
CY2013Q4	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0650
CY2013	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0650
CY2011	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	26000000	USD
CY2012	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	23900000	USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	21000000	USD
CY2011	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	USD
CY2013	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	71600000	USD
CY2012	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	800000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	67900000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	62700000	USD
CY2012	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	10500000	USD
CY2011	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	USD
CY2013	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	1600000	USD
CY2013	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2011	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	107900000	USD
CY2012	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2011	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	9600000	USD
CY2012	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	2200000	USD
CY2013	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	4800000	USD
CY2012	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	100000000	USD
CY2013	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	275000000	USD
CY2011	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	120000000	USD
CY2011	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	338000000	USD
CY2013	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	197000000	USD
CY2012	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	135000000	USD
CY2012	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2013	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	15200000	USD
CY2011	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-7300000	USD
CY2011	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	5000000	USD
CY2012	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2013	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2011	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10800000	USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2013Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10800000	USD
CY2011	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	1200000	USD
CY2013	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	16900000	USD
CY2012	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	300000	USD
CY2012	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2011	us-gaap	Profit Loss ProfitLoss	254600000	USD
CY2012	us-gaap	Profit Loss ProfitLoss	235900000	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	15300000	USD
CY2011	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2013	us-gaap	Profit Loss ProfitLoss	381400000	USD
CY2012Q1	us-gaap	Profit Loss ProfitLoss	56800000	USD
CY2012Q2	us-gaap	Profit Loss ProfitLoss	59900000	USD
CY2012Q4	us-gaap	Profit Loss ProfitLoss	59300000	USD
CY2012Q3	us-gaap	Profit Loss ProfitLoss	59900000	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	179000000	USD
CY2013Q4	us-gaap	Profit Loss ProfitLoss	64200000	USD
CY2013Q1	us-gaap	Profit Loss ProfitLoss	65900000	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	72300000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1430100000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1590600000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	910500000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	748000000	USD
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21000000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	27000000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	26000000	USD
CY2013Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	13500000	USD
CY2012Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	7200000	USD
CY2012Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	29400000	USD
CY2011Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	34400000	USD
CY2010Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	33600000	USD
CY2013Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	32600000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	13200000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	12100000	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	10100000	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	504900000	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	166200000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	62500000	USD
CY2012	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	245000000	USD
CY2013	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	152000000	USD
CY2011	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	306000000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	49300000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	52400000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2424700000	USD
CY2013Q4	us-gaap	Sale Leaseback Transaction Amount Due Under Financing Arrangement SaleLeasebackTransactionAmountDueUnderFinancingArrangement	28000000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2101100000	USD
CY2013	us-gaap	Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net Operating Revenues—</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We derived consolidated </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;"> from the following payor sources:</font></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicare</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicaid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workers' compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managed care and other discount plans, including Medicare Advantage</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other third-party payors</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patients</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize net patient service revenues in the reporting period in which we perform the service based on our current billing rates (i.e., gross charges), less actual adjustments and estimated discounts for contractual allowances (principally for patients covered by Medicare, Medicaid, and managed care and other health plans). We record gross service charges in our accounting records on an accrual basis using our established rates for the type of service provided to the patient. We recognize an estimated contractual allowance and an estimate of potential subsequent adjustments that may arise from post-payment and other reviews to reduce gross patient charges to the amount we estimate we will actually realize for the service rendered based upon previously agreed to rates with a payor. Our patient accounting system calculates contractual allowances on a patient-by-patient basis based on the rates in effect for each primary third-party payor. Other factors that are considered and could further influence the level of our reserves include the patient’s total length of stay for in-house patients, each patient’s discharge destination, the proportion of patients with secondary insurance coverage and the level of reimbursement under that secondary coverage, and the amount of charges that will be disallowed by payors. Such additional factors are assumed to remain consistent with the experience for patients discharged in similar time periods for the same payor classes, and additional reserves are provided to account for these factors. Payors include federal and state agencies, including Medicare and Medicaid, managed care health plans, commercial insurance companies, employers, and patients.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms that result from contract renegotiations and renewals. Due to complexities involved in determining amounts ultimately due under reimbursement arrangements with third-party payors, which are often subject to interpretation, we may receive reimbursement for healthcare services authorized and provided that is different from our estimates, and such differences could be material. In addition, laws and regulations governing the Medicare and Medicaid programs are complex, subject to interpretation, and are routinely modified for provider reimbursement. All healthcare providers participating in the Medicare and Medicaid programs are required to meet certain financial reporting requirements. Federal regulations require submission of annual cost reports covering medical costs and expenses associated with the services provided by each hospital to program beneficiaries. Annual cost reports required under the Medicare and Medicaid programs are subject to routine audits, which may result in adjustments to the amounts ultimately determined to be due to HealthSouth under these reimbursement programs. These audits often require several years to reach the final determination of amounts earned under the programs. If actual results are not consistent with our assumptions and judgments, we may be exposed to gains or losses that could be material.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CMS has been granted authority to suspend payments, in whole or in part, to Medicare providers if CMS possesses reliable information an overpayment, fraud, or willful misrepresentation exists. If CMS suspects payments are being made as the result of fraud or misrepresentation, CMS may suspend payment at any time without providing prior notice to us. The initial suspension period is limited to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">180</font><font style="font-family:inherit;font-size:10pt;"> days. However, the payment suspension period can be extended almost indefinitely if the matter is under investigation by the United States Department of Health and Human Services Office of Inspector General (the “HHS-OIG”) or the United States Department of Justice. Therefore, we are unable to predict if or when we may be subject to a suspension of payments by the Medicare and/or Medicaid programs, the possible length of the suspension period, or the potential cash flow impact of a payment suspension. Any such suspension would adversely impact our financial position, results of operations, and cash flows.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to legislative directives and authorizations from Congress, CMS has developed and instituted various Medicare audit programs under which CMS contracts with private companies to conduct claims and medical record audits. One type of audit contractor, the Recovery Audit Contractors (“RACs”), began post-payment audit processes in late 2009 for providers in general. In connection with CMS approved and announced RAC audits related to IRFs, we received requests in 2013 to review certain patient files for discharges occurring from 2010 to 2013. These post-payment RAC audits are focused on medical necessity requirements for admission to IRFs rather than targeting a specific diagnosis code as in previous pre-payment audits. Medical necessity is a subjective assessment by an independent physician of a patient’s ability to tolerate and benefit from intensive multi-disciplinary therapy provided in an IRF setting. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To date, the Medicare payments that are subject to these audit requests represent less than </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> of our Medicare patient discharges from 2010 to 2013, and not all of these patient file requests have resulted in payment denial determinations by the RACs. Because we have confidence in the medical judgment of both the referring and the admitting physicians who assess the treatment needs of their patients, we currently intend to appeal substantially all RAC denials arising from these audits using the same process we follow for appealing denials of certain diagnosis codes by Medicare Administrative Contractors (“MACs”) (see “Accounts Receivable and Allowance for Doubtful Accounts” below). Due to the delays announced by CMS in the related adjudication process, we believe the resolution of any claims that are subsequently denied as a result of these RAC audits could take in excess of two years. In addition, because we have limited experience with RACS in the context of post-payment reviews of this nature, we cannot provide assurance as to the future success of these disputes. As such, we make provisions for these claims based on our historical experience and success rates in the claim adjudication process. Because these reviews involve post-payment claims, there are no corresponding patient receivables in our consolidated balance sheet. As the ultimate results of these audits impact our estimates of amounts determined to be due to HealthSouth under these reimbursement programs, our provision for claims that are part of this post-payment review process are recorded to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;">. During 2013, we reduced our </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;"> by approximately </font><font style="font-family:inherit;font-size:10pt;">$8 million</font><font style="font-family:inherit;font-size:10pt;"> for post-payment claims that are part of this review process.</font></div></div>
CY2012Q4	us-gaap	Sale Leaseback Transaction Amount Due Under Financing Arrangement SaleLeasebackTransactionAmountDueUnderFinancingArrangement	28000000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.014
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.014
CY2013Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	140300000	USD
CY2012Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	148300000	USD
CY2011Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	153300000	USD
CY2010Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	152900000	USD
CY2013Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	42100000	USD
CY2012Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	41800000	USD
CY2013Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	98200000	USD
CY2012Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	106500000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	24100000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	20300000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	24800000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.418
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.428
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.415
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1991000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.45
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	17000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	141000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	29500000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2361000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2575000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.12
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.82
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y8M
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y2M
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25600000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	338000	shares
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8200000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	291000000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	344600000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	468700000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	403500000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	201000000	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2800000	USD
CY2012	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1200000	USD
CY2013	us-gaap	Stockholders Equity Other StockholdersEquityOther	-3200000	USD
CY2011	us-gaap	Stockholders Equity Other StockholdersEquityOther	1000000	USD
CY2012Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	342200000	USD
CY2013Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	93200000	USD
CY2011	us-gaap	Supplies Expense SuppliesExpense	102800000	USD
CY2013	us-gaap	Supplies Expense SuppliesExpense	105400000	USD
CY2012	us-gaap	Supplies Expense SuppliesExpense	102400000	USD
CY2011	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	7000000	USD
CY2013Q4	us-gaap	Temporary Equity Liquidation Preference Per Share TemporaryEquityLiquidationPreferencePerShare	1000
CY2012Q4	us-gaap	Temporary Equity Liquidation Preference Per Share TemporaryEquityLiquidationPreferencePerShare	1000
CY2013Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.10
CY2012Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.10
CY2013Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1500000	shares
CY2012Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1500000	shares
CY2012Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	353355	shares
CY2013Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	96245	shares
CY2006Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	400000	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5233521	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	14654436	shares
CY2013	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	9100000	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	404600000	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	163300000	USD
CY2011	us-gaap	Undistributed Earnings Allocated To Participating Securities UndistributedEarningsAllocatedToParticipatingSecurities	-3200000	USD
CY2013	us-gaap	Undistributed Earnings Allocated To Participating Securities UndistributedEarningsAllocatedToParticipatingSecurities	-3400000	USD
CY2012	us-gaap	Undistributed Earnings Allocated To Participating Securities UndistributedEarningsAllocatedToParticipatingSecurities	-2200000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12600000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6000000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	78000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2500000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1900000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3000000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	20200000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	900000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	121700000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	100000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1100000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	300000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	19800000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	75800000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	46700000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	400000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3200000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	400000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	76000000	USD
CY2013Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fifth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary	10100000	USD
CY2013Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	26300000	USD
CY2013Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fourth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary	10800000	USD
CY2013Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	26400000	USD
CY2013Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	22000000	USD
CY2013Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due After Five Years UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears	25800000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Assumptions—</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions are used for, but not limited to: (1) allowance for contractual revenue adjustments; (2) allowance for doubtful accounts; (3) asset impairments, including goodwill; (4) depreciable lives of assets; (5) useful lives of intangible assets; (6) economic lives and fair value of leased assets; (7) income tax valuation allowances; (8) uncertain tax positions; (9) fair value of stock options and restricted stock containing a market condition; (10) fair value of redeemable noncontrolling interests; (11) reserves for self-insured healthcare plans; (12) reserves for professional, workers’ compensation, and comprehensive general insurance liability risks; and (13) contingency and litigation reserves. Future events and their effects cannot be predicted with certainty; accordingly, our accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of our consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as our operating environment changes. We evaluate and update our assumptions and estimates on an ongoing basis and may employ outside experts to assist in our evaluation, as considered necessary. Actual results could differ from those estimates.</font></div></div>
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10500000	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	62400000	USD
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9100000	USD
CY2012	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-19700000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-21600000	USD
CY2011	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-22300000	USD
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109200000	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108100000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102100000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93300000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94600000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88100000	shares
CY2013Q4	hls	Accountsand Other Receivable Net AccountsandOtherReceivableNet	278400000	USD
CY2012Q4	hls	Accountsand Other Receivable Net AccountsandOtherReceivableNet	249300000	USD
CY2013	hls	Adjustmentsto Additional Paidin Capital Tax Impact Of Equity Componentof Convertible Debt AdjustmentstoAdditionalPaidinCapitalTaxImpactOfEquityComponentofConvertibleDebt	-28000000	USD
CY2012Q4	hls	Allowance For Doubtful Accounts As Percentage Of Patient Accounts Receivable AllowanceForDoubtfulAccountsAsPercentageOfPatientAccountsReceivable	0.110
CY2013Q4	hls	Allowance For Doubtful Accounts As Percentage Of Patient Accounts Receivable AllowanceForDoubtfulAccountsAsPercentageOfPatientAccountsReceivable	0.111
CY2013Q4	hls	Allowancefor Doubtful Accounts Receivable Currentand Noncurrent AllowanceforDoubtfulAccountsReceivableCurrentandNoncurrent	33100000	USD
CY2012Q4	hls	Allowancefor Doubtful Accounts Receivable Currentand Noncurrent AllowanceforDoubtfulAccountsReceivableCurrentandNoncurrent	28700000	USD
CY2011Q4	hls	Allowancefor Doubtful Accounts Receivable Currentand Noncurrent AllowanceforDoubtfulAccountsReceivableCurrentandNoncurrent	21400000	USD
CY2010Q4	hls	Allowancefor Doubtful Accounts Receivable Currentand Noncurrent AllowanceforDoubtfulAccountsReceivableCurrentandNoncurrent	22700000	USD
CY2009Q3	hls	Classof Warrant Exercise Priceof Warrants ClassofWarrantExercisePriceofWarrants	41.40
CY2013Q4	hls	Classof Warrant Exercise Priceof Warrants ClassofWarrantExercisePriceofWarrants	32.50
CY2012Q4	hls	Classof Warrant Exercise Priceof Warrants ClassofWarrantExercisePriceofWarrants	32.50
CY2009Q3	hls	Common Stock Shares Issued Consolidated Securities Action Settlement CommonStockSharesIssuedConsolidatedSecuritiesActionSettlement	5000000	shares
CY2009Q3	hls	Common Stock Warrants Issued Consolidated Securities Action Settlement CommonStockWarrantsIssuedConsolidatedSecuritiesActionSettlement	8200000	shares
CY2013Q4	hls	Compliance Threshold Under Health Care Act ComplianceThresholdUnderHealthCareAct	0.60
CY2006Q1	hls	Convertible Preferred Stock Conversion Price ConvertiblePreferredStockConversionPrice	30.50
CY2012	hls	Convertibledebtissued Convertibledebtissued	0	USD
CY2011	hls	Convertibledebtissued Convertibledebtissued	0	USD
CY2013	hls	Convertibledebtissued Convertibledebtissued	320000000	USD
CY2012Q4	hls	Deferred Tax Asset Property Plant And Equipment DeferredTaxAssetPropertyPlantAndEquipment	40300000	USD
CY2013Q4	hls	Deferred Tax Asset Property Plant And Equipment DeferredTaxAssetPropertyPlantAndEquipment	44300000	USD
CY2013Q4	hls	Deferredtaxliabilitiesconvertibledebtinterest Deferredtaxliabilitiesconvertibledebtinterest	28000000	USD
CY2012Q4	hls	Deferredtaxliabilitiesconvertibledebtinterest Deferredtaxliabilitiesconvertibledebtinterest	0	USD
CY2013	hls	Disposal Group Including Discontinued Operations Provision For Doubtful Accounts DisposalGroupIncludingDiscontinuedOperationsProvisionForDoubtfulAccounts	300000	USD
CY2011	hls	Disposal Group Including Discontinued Operations Provision For Doubtful Accounts DisposalGroupIncludingDiscontinuedOperationsProvisionForDoubtfulAccounts	-1500000	USD
CY2012	hls	Disposal Group Including Discontinued Operations Provision For Doubtful Accounts DisposalGroupIncludingDiscontinuedOperationsProvisionForDoubtfulAccounts	0	USD
CY2013Q4	hls	Divested Skilled Nursing Facility Beds DivestedSkilledNursingFacilityBeds	41
CY2012	hls	Effective Income Tax Rate Reconciliation Net Interest EffectiveIncomeTaxRateReconciliationNetInterest	-0.002
CY2011	hls	Effective Income Tax Rate Reconciliation Net Interest EffectiveIncomeTaxRateReconciliationNetInterest	-0.016
CY2013	hls	Effective Income Tax Rate Reconciliation Net Interest EffectiveIncomeTaxRateReconciliationNetInterest	-0.001
CY2013	hls	Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Adjustments EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAdjustments	0.000
CY2012	hls	Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Adjustments EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAdjustments	0.000
CY2011	hls	Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Adjustments EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAdjustments	0.029
CY2011	hls	Equity In Net Income Of Consolidated Affiliates EquityInNetIncomeOfConsolidatedAffiliates	0	USD
CY2012	hls	Equity In Net Income Of Consolidated Affiliates EquityInNetIncomeOfConsolidatedAffiliates	0	USD
CY2013	hls	Equity In Net Income Of Consolidated Affiliates EquityInNetIncomeOfConsolidatedAffiliates	0	USD
CY2013	hls	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-43600000	USD
CY2012	hls	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-48100000	USD
CY2011	hls	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-53100000	USD
CY2013Q4	hls	Equity Method Investments Cumulative Share Of Distributions EquityMethodInvestmentsCumulativeShareOfDistributions	-88800000	USD
CY2012Q4	hls	Equity Method Investments Cumulative Share Of Distributions EquityMethodInvestmentsCumulativeShareOfDistributions	-77400000	USD
CY2013Q4	hls	Equity Method Investments Cumulative Share Of Income EquityMethodInvestmentsCumulativeShareOfIncome	104800000	USD
CY2012Q4	hls	Equity Method Investments Cumulative Share Of Income EquityMethodInvestmentsCumulativeShareOfIncome	93800000	USD
CY2013Q4	hls	Fully Depreciated Assets FullyDepreciatedAssets	225000000	USD
CY2012Q4	hls	Fully Depreciated Assets FullyDepreciatedAssets	219000000	USD
CY2011	hls	Gain Loss On Disposition Of Assets Discontinued Operations GainLossOnDispositionOfAssetsDiscontinuedOperations	65600000	USD
CY2013	hls	Gain Loss On Disposition Of Assets Discontinued Operations GainLossOnDispositionOfAssetsDiscontinuedOperations	-400000	USD
CY2012	hls	Gain Loss On Disposition Of Assets Discontinued Operations GainLossOnDispositionOfAssetsDiscontinuedOperations	5000000	USD
CY2013	hls	Government Class Action And Related Settlements Expense GovernmentClassActionAndRelatedSettlementsExpense	-23500000	USD
CY2011	hls	Government Class Action And Related Settlements Expense GovernmentClassActionAndRelatedSettlementsExpense	-12300000	USD
CY2012	hls	Government Class Action And Related Settlements Expense GovernmentClassActionAndRelatedSettlementsExpense	-3500000	USD
CY2013	hls	Healthcare Plan Expense HealthcarePlanExpense	73400000	USD
CY2012	hls	Healthcare Plan Expense HealthcarePlanExpense	67800000	USD
CY2011	hls	Healthcare Plan Expense HealthcarePlanExpense	66800000	USD
CY2011	hls	Income Lossfrom Continuing Operations Attributableto Common Shareholders Basicand Diluted IncomeLossfromContinuingOperationsAttributabletoCommonShareholdersBasicandDiluted	129600000	USD
CY2012	hls	Income Lossfrom Continuing Operations Attributableto Common Shareholders Basicand Diluted IncomeLossfromContinuingOperationsAttributabletoCommonShareholdersBasicandDiluted	153600000	USD
CY2013	hls	Income Lossfrom Continuing Operations Attributableto Common Shareholders Basicand Diluted IncomeLossfromContinuingOperationsAttributabletoCommonShareholdersBasicandDiluted	228700000	USD
CY2011	hls	Income Tax Benefit Resulting From Tax Settlement IncomeTaxBenefitResultingFromTaxSettlement	18000000	USD
CY2011	hls	Increase Decrease In Refunds Due Patients And Other Third Party Payors IncreaseDecreaseInRefundsDuePatientsAndOtherThirdPartyPayors	-16200000	USD
CY2013	hls	Increase Decrease In Refunds Due Patients And Other Third Party Payors IncreaseDecreaseInRefundsDuePatientsAndOtherThirdPartyPayors	-400000	USD
CY2012	hls	Increase Decrease In Refunds Due Patients And Other Third Party Payors IncreaseDecreaseInRefundsDuePatientsAndOtherThirdPartyPayors	2700000	USD
CY2013Q4	hls	Initial Suspension Period Medicare Payments InitialSuspensionPeriodMedicarePayments	180	D
CY2013Q4	hls	Investments Total InvestmentsTotal	164500000	USD
CY2012Q4	hls	Investments Total InvestmentsTotal	237900000	USD
CY2011Q3	hls	Long Lived Assets Held For Sale Purchase Price LongLivedAssetsHeldForSalePurchasePrice	117500000	USD
CY2013Q4	hls	Maximum Self Insured Risk MaximumSelfInsuredRisk	24000000	USD
CY2013Q4	hls	Medicare Denials Percentage Collected After Appeal MedicareDenialsPercentageCollectedAfterAppeal	0.58
CY2013Q4	hls	Medicare Denials Percentage Collected After Appeal Including Administrative Law Judge Hearings MedicareDenialsPercentageCollectedAfterAppealIncludingAdministrativeLawJudgeHearings	0.70
CY2013Q4	hls	Minimum Amount Of Loss Contingency To Consider When Accruing Estimate Of Related Legal Fees MinimumAmountOfLossContingencyToConsiderWhenAccruingEstimateOfRelatedLegalFees	5000000	USD
CY2012	hls	Net Income Loss Availableto Common Stockholders NetIncomeLossAvailabletoCommonStockholders	158000000	USD
CY2013	hls	Net Income Loss Availableto Common Stockholders NetIncomeLossAvailabletoCommonStockholders	227600000	USD
CY2011	hls	Net Income Loss Availableto Common Stockholders NetIncomeLossAvailabletoCommonStockholders	178300000	USD
CY2013	hls	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest Total NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterestTotal	375600000	USD
CY2011	hls	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest Total NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterestTotal	251000000	USD
CY2012	hls	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest Total NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterestTotal	232100000	USD
CY2013	hls	Net Operating Revenues Less Provision For Doubtful Accounts NetOperatingRevenuesLessProvisionForDoubtfulAccounts	2247200000	USD
CY2012	hls	Net Operating Revenues Less Provision For Doubtful Accounts NetOperatingRevenuesLessProvisionForDoubtfulAccounts	2134900000	USD
CY2011	hls	Net Operating Revenues Less Provision For Doubtful Accounts NetOperatingRevenuesLessProvisionForDoubtfulAccounts	2005900000	USD
CY2011	hls	Net Operating Revenues Less Provision For Doubtful Accounts Discontinued Operations NetOperatingRevenuesLessProvisionForDoubtfulAccountsDiscontinuedOperations	94200000	USD
CY2013	hls	Net Operating Revenues Less Provision For Doubtful Accounts Discontinued Operations NetOperatingRevenuesLessProvisionForDoubtfulAccountsDiscontinuedOperations	500000	USD
CY2012	hls	Net Operating Revenues Less Provision For Doubtful Accounts Discontinued Operations NetOperatingRevenuesLessProvisionForDoubtfulAccountsDiscontinuedOperations	1000000	USD
CY2013Q4	hls	Number Of General Or Limited Partnerships Limited Liability Companies Or Joint Ventures NumberOfGeneralOrLimitedPartnershipsLimitedLiabilityCompaniesOrJointVentures	9	facilities
CY2013Q4	hls	Number Of Hospital Based Home Health Agencies NumberOfHospitalBasedHomeHealthAgencies	25	facilities
CY2013Q4	hls	Number Of Hospitals Sole Ownership NumberOfHospitalsSoleOwnership	72	facilities
CY2012Q4	hls	Number Of Individual Claims Covered By Self Insured Risk Reserves NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves	800
CY2013Q4	hls	Number Of Individual Claims Covered By Self Insured Risk Reserves NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves	1150
CY2013Q4	hls	Number Of Inpatient Rehabilitation Hospitals NumberOfInpatientRehabilitationHospitals	103	facilities
CY2013Q4	hls	Number Of Inpatient Rehabilitation Units Under Management Contracts NumberOfInpatientRehabilitationUnitsUnderManagementContracts	3
CY2013Q4	hls	Number Of Joint Venture Hospitals Accounted For Using Equity Method NumberOfJointVentureHospitalsAccountedForUsingEquityMethod	2	facilities
CY2013Q4	hls	Number Of Jointly Owned Hospitals NumberOfJointlyOwnedHospitals	31	facilities
CY2011Q3	hls	Number Of Long Term Acute Care Hospitals Sold NumberOfLongTermAcuteCareHospitalsSold	5	facilities
CY2013Q4	hls	Number Of Outpatient Rehabilitation Satellite Clinics NumberOfOutpatientRehabilitationSatelliteClinics	20	facilities
CY2013Q4	hls	Number Of Partially Owned Subsidiaries Nonconsolidated NumberOfPartiallyOwnedSubsidiariesNonconsolidated	12	facilities
CY2013Q4	hls	Number Of Sale Leaseback Transactions NumberOfSaleLeasebackTransactions	2
CY2013	hls	Occupancy Cost OccupancyCost	47000000	USD
CY2011	hls	Occupancy Cost OccupancyCost	48400000	USD
CY2012	hls	Occupancy Cost OccupancyCost	48600000	USD
CY2013Q4	hls	Operating And Capital Leases Future Minimum Payments Due OperatingAndCapitalLeasesFutureMinimumPaymentsDue	429400000	USD
CY2013Q4	hls	Operating And Capital Leases Future Minimum Payments Due Current OperatingAndCapitalLeasesFutureMinimumPaymentsDueCurrent	50200000	USD
CY2013Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Five Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInFiveYears	35500000	USD
CY2013Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Four Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInFourYears	39700000	USD
CY2013Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Three Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInThreeYears	44500000	USD
CY2013Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Two Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInTwoYears	49600000	USD
CY2013Q4	hls	Operating And Capital Leases Future Minimum Payments Due Thereafter OperatingAndCapitalLeasesFutureMinimumPaymentsDueThereafter	209900000	USD
CY2012Q3	hls	Operating Earnings OperatingEarnings	94400000	USD
CY2012Q4	hls	Operating Earnings OperatingEarnings	95500000	USD
CY2012Q1	hls	Operating Earnings OperatingEarnings	96100000	USD
CY2012Q2	hls	Operating Earnings OperatingEarnings	92700000	USD
CY2012	hls	Operating Earnings OperatingEarnings	378700000	USD
CY2013Q2	hls	Operating Earnings OperatingEarnings	101100000	USD
CY2013Q1	hls	Operating Earnings OperatingEarnings	108700000	USD
CY2013Q3	hls	Operating Earnings OperatingEarnings	119000000	USD
CY2013Q4	hls	Operating Earnings OperatingEarnings	106900000	USD
CY2013	hls	Operating Earnings OperatingEarnings	435700000	USD
CY2013Q4	hls	Operating Lease Term Maximum OperatingLeaseTermMaximum	15	Y
CY2013Q4	hls	Operating Lease Term Minimum OperatingLeaseTermMinimum	3	Y
CY2011	hls	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	4200000	USD
CY2013	hls	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	4200000	USD
CY2012	hls	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	4500000	USD
CY2007Q4	hls	Option Contract Annual Premium OptionContractAnnualPremium	0.15
CY2007Q4	hls	Option Contract Exercisable OptionContractExercisable	0.30
CY2012Q4	hls	Other Notes Payable Other OtherNotesPayableOther	3100000	USD
CY2013Q4	hls	Other Notes Payable Other OtherNotesPayableOther	1800000	USD
CY2013	hls	Ownership Percentage Of Subsidiary Guarantors OwnershipPercentageOfSubsidiaryGuarantors	1.00
CY2012Q4	hls	Patient Accounts Receivable Net Current PatientAccountsReceivableNetCurrent	231300000	USD
CY2013Q4	hls	Patient Accounts Receivable Net Current PatientAccountsReceivableNetCurrent	249400000	USD
CY2013Q4	hls	Patient Accounts Receivable Net Noncurrent PatientAccountsReceivableNetNoncurrent	16600000	USD
CY2012Q4	hls	Patient Accounts Receivable Net Noncurrent PatientAccountsReceivableNetNoncurrent	0	USD
CY2012	hls	Percentage Of Net Operating Revenues Managed Care PercentageOfNetOperatingRevenuesManagedCare	0.193
CY2011	hls	Percentage Of Net Operating Revenues Managed Care PercentageOfNetOperatingRevenuesManagedCare	0.198
CY2013	hls	Percentage Of Net Operating Revenues Managed Care PercentageOfNetOperatingRevenuesManagedCare	0.185
CY2013	hls	Percentage Of Net Operating Revenues Medicaid PercentageOfNetOperatingRevenuesMedicaid	0.012
CY2011	hls	Percentage Of Net Operating Revenues Medicaid PercentageOfNetOperatingRevenuesMedicaid	0.016
CY2012	hls	Percentage Of Net Operating Revenues Medicaid PercentageOfNetOperatingRevenuesMedicaid	0.012
CY2012	hls	Percentage Of Net Operating Revenues Medicare PercentageOfNetOperatingRevenuesMedicare	0.734
CY2011	hls	Percentage Of Net Operating Revenues Medicare PercentageOfNetOperatingRevenuesMedicare	0.720
CY2013	hls	Percentage Of Net Operating Revenues Medicare PercentageOfNetOperatingRevenuesMedicare	0.745
CY2011	hls	Percentage Of Net Operating Revenues Other Income PercentageOfNetOperatingRevenuesOtherIncome	0.018
CY2012	hls	Percentage Of Net Operating Revenues Other Income PercentageOfNetOperatingRevenuesOtherIncome	0.015
CY2013	hls	Percentage Of Net Operating Revenues Other Income PercentageOfNetOperatingRevenuesOtherIncome	0.017
CY2011	hls	Percentage Of Net Operating Revenues Other Third Party Payors PercentageOfNetOperatingRevenuesOtherThirdPartyPayors	0.020
CY2012	hls	Percentage Of Net Operating Revenues Other Third Party Payors PercentageOfNetOperatingRevenuesOtherThirdPartyPayors	0.018
CY2013	hls	Percentage Of Net Operating Revenues Other Third Party Payors PercentageOfNetOperatingRevenuesOtherThirdPartyPayors	0.018
CY2012	hls	Percentage Of Net Operating Revenues Patients PercentageOfNetOperatingRevenuesPatients	0.013
CY2013	hls	Percentage Of Net Operating Revenues Patients PercentageOfNetOperatingRevenuesPatients	0.011
CY2011	hls	Percentage Of Net Operating Revenues Patients PercentageOfNetOperatingRevenuesPatients	0.012
CY2011	hls	Percentage Of Net Operating Revenues Total PercentageOfNetOperatingRevenuesTotal	1.000
CY2013	hls	Percentage Of Net Operating Revenues Total PercentageOfNetOperatingRevenuesTotal	1.000
CY2012	hls	Percentage Of Net Operating Revenues Total PercentageOfNetOperatingRevenuesTotal	1.000
CY2011	hls	Percentage Of Net Operating Revenues Workers Compensation PercentageOfNetOperatingRevenuesWorkersCompensation	0.016
CY2012	hls	Percentage Of Net Operating Revenues Workers Compensation PercentageOfNetOperatingRevenuesWorkersCompensation	0.015
CY2013	hls	Percentage Of Net Operating Revenues Workers Compensation PercentageOfNetOperatingRevenuesWorkersCompensation	0.012
CY2013Q4	hls	Percentage Of Net Patient Service Accounts Receivable PercentageOfNetPatientServiceAccountsReceivable	1.000
CY2012Q4	hls	Percentage Of Net Patient Service Accounts Receivable PercentageOfNetPatientServiceAccountsReceivable	1.000
CY2013Q4	hls	Percentage Of Net Patient Service Accounts Receivable Managed Care And Other Discount Plans PercentageOfNetPatientServiceAccountsReceivableManagedCareAndOtherDiscountPlans	0.224
CY2012Q4	hls	Percentage Of Net Patient Service Accounts Receivable Managed Care And Other Discount Plans PercentageOfNetPatientServiceAccountsReceivableManagedCareAndOtherDiscountPlans	0.258
CY2012Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicaid PercentageOfNetPatientServiceAccountsReceivableMedicaid	0.021
CY2013Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicaid PercentageOfNetPatientServiceAccountsReceivableMedicaid	0.020
CY2013Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicare PercentageOfNetPatientServiceAccountsReceivableMedicare	0.674
CY2012Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicare PercentageOfNetPatientServiceAccountsReceivableMedicare	0.628
CY2012Q4	hls	Percentage Of Net Patient Service Accounts Receivable Other Third Party Payors PercentageOfNetPatientServiceAccountsReceivableOtherThirdPartyPayors	0.043
CY2013Q4	hls	Percentage Of Net Patient Service Accounts Receivable Other Third Party Payors PercentageOfNetPatientServiceAccountsReceivableOtherThirdPartyPayors	0.040
CY2013Q4	hls	Percentage Of Net Patient Service Accounts Receivable Patients PercentageOfNetPatientServiceAccountsReceivablePatients	0.016
CY2012Q4	hls	Percentage Of Net Patient Service Accounts Receivable Patients PercentageOfNetPatientServiceAccountsReceivablePatients	0.020
CY2012Q4	hls	Percentage Of Net Patient Service Accounts Receivable Workers Compensation PercentageOfNetPatientServiceAccountsReceivableWorkersCompensation	0.030
CY2013Q4	hls	Percentage Of Net Patient Service Accounts Receivable Workers Compensation PercentageOfNetPatientServiceAccountsReceivableWorkersCompensation	0.026
CY2008Q1	hls	Percentage Of Net Profit Due Company From Hospital Building Sale PercentageOfNetProfitDueCompanyFromHospitalBuildingSale	0.40
CY2013Q4	hls	Percentage Of Ownership In Jointly Owned Hospitals Maximum PercentageOfOwnershipInJointlyOwnedHospitalsMaximum	0.975
CY2013Q4	hls	Percentage Of Ownership In Jointly Owned Hospitals Minimum PercentageOfOwnershipInJointlyOwnedHospitalsMinimum	0.500
CY2013Q4	hls	Percentageofassetspledgedtolendersundercreditagreement Percentageofassetspledgedtolendersundercreditagreement	0.79
CY2011	hls	Premium Paid On Redemption Of Bonds PremiumPaidOnRedemptionOfBonds	26900000	USD
CY2013	hls	Premium Paid On Redemption Of Bonds PremiumPaidOnRedemptionOfBonds	1700000	USD
CY2012	hls	Premium Paid On Redemption Of Bonds PremiumPaidOnRedemptionOfBonds	1900000	USD
CY2013	hls	Premium Received On Bond Issuance PremiumReceivedOnBondIssuance	0	USD
CY2012	hls	Premium Received On Bond Issuance PremiumReceivedOnBondIssuance	0	USD
CY2011	hls	Premium Received On Bond Issuance PremiumReceivedOnBondIssuance	4100000	USD
CY2013	hls	Professional Fees Accounting Tax And Legal ProfessionalFeesAccountingTaxAndLegal	9500000	USD
CY2012	hls	Professional Fees Accounting Tax And Legal ProfessionalFeesAccountingTaxAndLegal	16100000	USD
CY2011	hls	Professional Fees Accounting Tax And Legal ProfessionalFeesAccountingTaxAndLegal	21000000	USD
CY2013Q4	hls	Property And Equipment Net Excluding Cip PropertyAndEquipmentNetExcludingCIP	878000000	USD
CY2012Q4	hls	Property And Equipment Net Excluding Cip PropertyAndEquipmentNetExcludingCIP	702000000	USD
CY2012	hls	Provision For Government Class Action And Related Settlements Expense ProvisionForGovernmentClassActionAndRelatedSettlementsExpense	-3500000	USD
CY2011	hls	Provision For Government Class Action And Related Settlements Expense ProvisionForGovernmentClassActionAndRelatedSettlementsExpense	-12300000	USD
CY2013	hls	Provision For Government Class Action And Related Settlements Expense ProvisionForGovernmentClassActionAndRelatedSettlementsExpense	-23500000	USD
CY2013	hls	Reductionin Net Operating Revenue Post Payment Claims ReductioninNetOperatingRevenuePostPaymentClaims	8000000	USD
CY2013	hls	Repurchaseofpreferredstock Repurchaseofpreferredstock	320000000	USD
CY2012	hls	Repurchaseofpreferredstock Repurchaseofpreferredstock	0	USD
CY2011	hls	Repurchaseofpreferredstock Repurchaseofpreferredstock	0	USD
CY2013Q4	hls	Retirement Investment Plan Age Requirement RetirementInvestmentPlanAgeRequirement	21
CY2013	hls	Retirement Investment Plan Company Match RetirementInvestmentPlanCompanyMatch	50% of the first 6% of each participant’s elective deferrals
CY2013	hls	Retirement Investment Plan Company Match Funded By Plan Forfeiture Account RetirementInvestmentPlanCompanyMatchFundedByPlanForfeitureAccount	500000	USD
CY2012	hls	Retirement Investment Plan Company Match Funded By Plan Forfeiture Account RetirementInvestmentPlanCompanyMatchFundedByPlanForfeitureAccount	800000	USD
CY2011	hls	Retirement Investment Plan Company Match Funded By Plan Forfeiture Account RetirementInvestmentPlanCompanyMatchFundedByPlanForfeitureAccount	1700000	USD
CY2011	hls	Retirement Investment Plan Company Match Total Costs RetirementInvestmentPlanCompanyMatchTotalCosts	12600000	USD
CY2012	hls	Retirement Investment Plan Company Match Total Costs RetirementInvestmentPlanCompanyMatchTotalCosts	13200000	USD
CY2013	hls	Retirement Investment Plan Company Match Total Costs RetirementInvestmentPlanCompanyMatchTotalCosts	13200000	USD
CY2013Q4	hls	Retirement Investment Plan Company Match Vesting Percentage RetirementInvestmentPlanCompanyMatchVestingPercentage	1.00
CY2013Q4	hls	Retirement Investment Plan Company Match Vesting Period RetirementInvestmentPlanCompanyMatchVestingPeriod	3	Y
CY2013Q4	hls	Retirement Investment Plan Maximum Employee Contribution RetirementInvestmentPlanMaximumEmployeeContribution	1.00
CY2013	hls	Revolver Amounts Drawn RevolverAmountsDrawn	45000000	USD
CY2011Q4	hls	Self Insurance Reserves Netof Reinsurance Receivables SelfInsuranceReservesNetofReinsuranceReceivables	118900000	USD
CY2013Q4	hls	Self Insurance Reserves Netof Reinsurance Receivables SelfInsuranceReservesNetofReinsuranceReceivables	107700000	USD
CY2012Q4	hls	Self Insurance Reserves Netof Reinsurance Receivables SelfInsuranceReservesNetofReinsuranceReceivables	118900000	USD
CY2010Q4	hls	Self Insurance Reserves Netof Reinsurance Receivables SelfInsuranceReservesNetofReinsuranceReceivables	119300000	USD
CY2011	hls	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	12800000	USD
CY2013	hls	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	12400000	USD
CY2012	hls	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	11400000	USD
CY2012Q4	hls	Senior Notes Issuance Proceeds Used For Debt Reduction SeniorNotesIssuanceProceedsUsedForDebtReduction	64500000	USD
CY2011	hls	Senior Notes Issuance Proceeds Used For Debt Reduction SeniorNotesIssuanceProceedsUsedForDebtReduction	45000000	USD
CY2011Q1	hls	Senior Notes Proceeds From Public Offering SeniorNotesProceedsFromPublicOffering	122000000	USD
CY2013Q4	hls	Senior Notes Repurchase Price Change In Control SeniorNotesRepurchasePriceChangeInControl	1.01
CY2013Q4	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsExercisableWeightedAverageRemainingContractualTerm	3.8	Y
CY2013	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	24.39
CY2013	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsExpirationsInPeriodWeightedAverageExercisePrice	24.47
CY2013	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2013	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	24.17
CY2012	hls	Shareholders Equity Decreased Due To Reclassification Adjustment ShareholdersEquityDecreasedDueToReclassificationAdjustment	600000	USD
CY2013Q3	hls	Statistical Confidence Level StatisticalConfidenceLevel	0.70
CY2009Q3	hls	Stock Warrants Issued Term StockWarrantsIssuedTerm	7	Y
CY2012	hls	Temporary Equity Increased Due To Reclassification Adjustment TemporaryEquityIncreasedDueToReclassificationAdjustment	7200000	USD
CY2012	hls	Total Assets Increased Due To Reclassification Adjustment TotalAssetsIncreasedDueToReclassificationAdjustment	400000	USD
CY2012	hls	Total Liabilities Decreased Due To Reclassification Adjustment TotalLiabilitiesDecreasedDueToReclassificationAdjustment	6200000	USD
CY2012	hls	Treasury Stock Reacquired TreasuryStockReacquired	11900000	USD
CY2013	hls	Treasury Stock Reacquired TreasuryStockReacquired	5800000	USD
CY2013	hls	Treasury Stock Value Acquired Cost Method Common Stock TreasuryStockValueAcquiredCostMethodCommonStock	234100000	USD
CY2013	hls	Treasury Stock Value Acquired Cost Method Preferred Stock TreasuryStockValueAcquiredCostMethodPreferredStock	71600000	USD
CY2011	hls	Undistributed Earnings From Discontinued Operations Allocatedto Participating Securities UndistributedEarningsFromDiscontinuedOperationsAllocatedtoParticipatingSecurities	-1200000	USD
CY2012	hls	Undistributed Earnings From Discontinued Operations Allocatedto Participating Securities UndistributedEarningsFromDiscontinuedOperationsAllocatedtoParticipatingSecurities	-100000	USD
CY2013	hls	Undistributed Earnings From Discontinued Operations Allocatedto Participating Securities UndistributedEarningsFromDiscontinuedOperationsAllocatedtoParticipatingSecurities	0	USD
CY2013	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2013	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2012	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2012	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2013	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	300000	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2012	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedReductionsResultingFromLapseOfApplicableStatuteOfLimitations	100000	USD
CY2013	hls	Warrants Exercised Value WarrantsExercisedValue	15300000	USD
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0000785161
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88000335	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	2500000000	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	HEALTHSOUTH CORP
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes

Files In Submission

Name	View Source	Status
0000785161-14-000013-index-headers.html	Edgar Link	pending
0000785161-14-000013-index.html	Edgar Link	pending
0000785161-14-000013.txt	Edgar Link	pending
0000785161-14-000013-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hls-20131231.xml	Edgar Link	completed
hls-20131231.xsd	Edgar Link	pending
hls-20131231_cal.xml	Edgar Link	unprocessable
hls-20131231_def.xml	Edgar Link	unprocessable
hls-20131231_lab.xml	Edgar Link	unprocessable
hls-20131231_pre.xml	Edgar Link	unprocessable
hls10-k123113ex104.htm	Edgar Link	pending
hls10-k123113ex109.htm	Edgar Link	pending
hls10k123113.htm	Edgar Link	pending
hls10k123113ex12.htm	Edgar Link	pending
hls10k123113ex21.htm	Edgar Link	pending
hls10k123113ex23.htm	Edgar Link	pending
hls10k123113ex311.htm	Edgar Link	pending
hls10k123113ex312.htm	Edgar Link	pending
hls10k123113ex321.htm	Edgar Link	pending
hls10k123113ex322.htm	Edgar Link	pending
hls10k1231_chart-06434.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EHC
Encompass Health Corp Stock $ehc

2013 Q4 Form 10-K Financial Statement

#000078516114000013 Filed on February 20, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHC Encompass Health Corp Stock $ehc

2013 Q4 Form 10-K Financial Statement

#000078516114000013 Filed on February 20, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHC
Encompass Health Corp Stock $ehc